Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Wolfe Research Downgrades Qualys to Peer Perform

Wolfe Research Downgrades Qualys to Peer Perform

Wolfe Research analyst Joshua Tilton downgrades Qualys (NASDAQ:QLYS) from Outperform to Peer Perform.

byBenzinga Newsdesk

February 13, 2023

1 minute read

Wolfe Research analyst Joshua Tilton downgrades Qualys (NASDAQ:QLYS) from Outperform to Peer Perform.

News

Overview Of Value Stocks In The Consumer Defensive Sector

By Benzinga Insights

August 11, 10:40 AM

What is a Value Stock? A value stock is traditionally defined in terms of how investors in the…

CHGG

Mizuho Maintains Buy on Microsoft, Lowers Price Target to $340

By Benzinga Newsdesk

July 19, 9:57 AM

Mizuho analyst Gregg Moskowitz maintains Microsoft (NASDAQ:MSFT) with a Buy and lowers the price target from $350 to $340.

MSFT

Kineta Provides Update On Its Ongoing Phase 1/2 VISTA-101 Clinical Trial Of KVA12123 In Patients With Advanced Solid Tumors

By Benzinga Newsdesk

January 17, 9:31 AM

Cleared First Four Monotherapy Doses and Initial Combination Cohort with No Dose Limiting Toxicities at any Dose LevelKVA12123 Monotherapy Demonstrated Dose Proportional Induction of Pro-inflammatory Biomarkers Required

Analyst Ratings

Where Catalent Stands With Analysts

By Benzinga Insights

April 3, 3:00 PM

Analysts have provided the following ratings for Catalent (NYSE:CTLT) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

CTLT

Wolfe Research Downgrades Qualys to Peer Perform

Related Posts

Overview Of Value Stocks In The Consumer Defensive Sector

Mizuho Maintains Buy on Microsoft, Lowers Price Target to $340

Kineta Provides Update On Its Ongoing Phase 1/2 VISTA-101 Clinical Trial Of KVA12123 In Patients With Advanced Solid Tumors

Where Catalent Stands With Analysts